New Frontiers in NSCLC: The Promise and Progress of HER2-Directed Therapies

Are you aware of the new therapies revolutionizing the treatment armamentarium for patients with HER2-mutated disease? Credit available for this activity expires: 11/25/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001833?ecd=bdc_podcast_libsyn_mscpedu